IDEXX Laboratories, Inc.
NASDAQIDEXX Laboratories heads into its May 5 Q1 earnings call with the stock under pressure, short interest at a one-month high, and analysts cutting targets — a convergence that raises the stakes on next week's print. The most visible story of the week is from the Street. Analyst targets have been moving in one direction. UBS slashed its price target to $640 from $730 on April 28…
Snapshot as of 9 May 2026
IDEXX Laboratories heads into its May 5 Q1 earnings call with the stock under pressure, short interest at a one-month high, and analysts cutting targets — a convergence that raises the stakes on next week's print. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IDXX — free to start on ORTEX.
Sign up for free →Open IDXX on ORTEX